TY - JOUR
T1 - Machine Learning in Cardiology—Ensuring Clinical Impact Lives Up to the Hype
AU - Russak, Adam J.
AU - Chaudhry, Farhan
AU - De Freitas, Jessica K.
AU - Baron, Garrett
AU - Chaudhry, Fayzan F.
AU - Bienstock, Solomon
AU - Paranjpe, Ishan
AU - Vaid, Akhil
AU - Ali, Mohsin
AU - Zhao, Shan
AU - Somani, Sulaiman
AU - Richter, Felix
AU - Bawa, Tejeshwar
AU - Levy, Phillip D.
AU - Miotto, Riccardo
AU - Nadkarni, Girish N.
AU - Johnson, Kipp W.
AU - Glicksberg, Benjamin S.
N1 - Publisher Copyright:
© The Author(s) 2020.
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Despite substantial advances in the study, treatment, and prevention of cardiovascular disease, numerous challenges relating to optimally screening, diagnosing, and managing patients remain. Simultaneous improvements in computing power, data storage, and data analytics have led to the development of new techniques to address these challenges. One powerful tool to this end is machine learning (ML), which aims to algorithmically identify and represent structure within data. Machine learning’s ability to efficiently analyze large and highly complex data sets make it a desirable investigative approach in modern biomedical research. Despite this potential and enormous public and private sector investment, few prospective studies have demonstrated improved clinical outcomes from this technology. This is particularly true in cardiology, despite its emphasis on objective, data-driven results. This threatens to stifle ML’s growth and use in mainstream medicine. We outline the current state of ML in cardiology and outline methods through which impactful and sustainable ML research can occur. Following these steps can ensure ML reaches its potential as a transformative technology in medicine.
AB - Despite substantial advances in the study, treatment, and prevention of cardiovascular disease, numerous challenges relating to optimally screening, diagnosing, and managing patients remain. Simultaneous improvements in computing power, data storage, and data analytics have led to the development of new techniques to address these challenges. One powerful tool to this end is machine learning (ML), which aims to algorithmically identify and represent structure within data. Machine learning’s ability to efficiently analyze large and highly complex data sets make it a desirable investigative approach in modern biomedical research. Despite this potential and enormous public and private sector investment, few prospective studies have demonstrated improved clinical outcomes from this technology. This is particularly true in cardiology, despite its emphasis on objective, data-driven results. This threatens to stifle ML’s growth and use in mainstream medicine. We outline the current state of ML in cardiology and outline methods through which impactful and sustainable ML research can occur. Following these steps can ensure ML reaches its potential as a transformative technology in medicine.
KW - artificial intelligence
KW - cardiology
KW - cardiovascular disease
KW - deep learning
KW - machine learning
UR - http://www.scopus.com/inward/record.url?scp=85085949607&partnerID=8YFLogxK
U2 - 10.1177/1074248420928651
DO - 10.1177/1074248420928651
M3 - Review article
C2 - 32495652
AN - SCOPUS:85085949607
SN - 1074-2484
VL - 25
SP - 379
EP - 390
JO - Journal of Cardiovascular Pharmacology and Therapeutics
JF - Journal of Cardiovascular Pharmacology and Therapeutics
IS - 5
ER -